Latko Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.82M Sell
37,505
-2,827
-7% -$331K 2.05% 14
2026
Q1
$4.85M Buy
40,332
+15,113
+60% +$1.74M 2.37% 13
2025
Q4
$2.65M Sell
25,219
-254
-1% -$23.8K 1.3% 17
2025
Q3
$2.14M Sell
25,473
-1,073
-4% -$88.4K 1.08% 17
2025
Q2
$2.1M Sell
26,546
-888
-3% -$70.6K 1.18% 15
2025
Q1
$2.46M Buy
27,434
+219
+0.8% +$20.4K 1.6% 13
2024
Q4
$2.71M Sell
27,215
-1,810
-6% -$187K 1.6% 13
2024
Q3
$3.3M Buy
+29,025
New +$3.45M 2% 11

Other funds holding MRK

Latko Wealth Management's MRK Position: Q2 2026 in Review

Latko Wealth Management reduced its Merck (MRK) stake by 7% in Q2 2026, selling an estimated $331K and leaving 37,505 shares worth $4.82M. The position accounts for 2.05% of the portfolio, ranked #14.

Latko Wealth Management first reported a position in MRK in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.85M in Q1 2026. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Latko Wealth Management held 37,505 shares of Merck worth $4.82M as of Q2 2026.
  • Latko Wealth Management sold 2,827 Merck shares in Q2 2026, an estimated $331K.
  • Merck made up 2.05% of Latko Wealth Management's portfolio in Q2 2026, its #14 holding.
  • Latko Wealth Management first reported a position in Merck in Q3 2024 and has held it in 8 quarters since.
  • Latko Wealth Management's Merck position peaked at $4.85M in Q1 2026.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Latko Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.